Company intelligence / Profile preview

EmeritusDX

Irvine / Lake Forest / Los Angeles, California, United Statesemeritus.org ↗

Ownership: Private
Development stage: Commercial

Overview

EmeritusDX is a rapidly growing cancer diagnostics and information company specializing in delivering actionable clinical information through non-invasive, early detection, precision medicine, and personalized treatment solutions. It operates state-of-the-art laboratories providing timely and accurate results to guide diagnosis and treatment of cancer patients. The company's recent expansion includes acquiring Sprint Diagnostics to enhance its pharma service offerings.

Therapeutic areas: OncologyNeurology
Modalities: Non-pharmacological therapy (diagnostic testing)
Industry: Pathology

Partnerships

PathMD

Beyond the preview

Go deeper on EmeritusDX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmeritusDX.

Explore the full profile